SUBSCRIBE
SUBSCRIBE
News   Business

Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals Incorporated’s Board of Directors

July 8, 2009 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that Jeffrey Leiden, M.D., Ph.D. and Dennis Winger joined its board of directors.
People
Vertex Pharmaceuticals
MORE ON THIS TOPIC
3D illustration of hair root growing from skin cells, symbolizing strength, growth, and nourishment. Perfect for haircare, cosmetic advertising, medical research, and healthcare concepts.
Funding
Veradermics Gets $150M Series C To Advance Hair Regrowth Pill
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing three businesspeople hanging on the edge of a cliff
Layoffs
Q3 Layoffs Up 280% YOY With CSL, Merck, Novo’s Restructurings
October 16, 2025
 · 
4 min read
 · 
Angela Gabriel
Facade of Novo Nordisk's office in Fremont, California
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
October 15, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Hair care treatment and repair, follicles with damaged structure and split ends, healthy on beige background 3d render icon set. Cosmetic product with keratin, shampoo mockup banner, 3D illustration
Funding
Pelage Pharmaceuticals Raises $120 Million To Grow Hair Loss Program
October 15, 2025
 · 
2 min read
 · 
Dan Samorodnitsky